<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01306565</url>
  </required_header>
  <id_info>
    <org_study_id>Atorvastatin and CRP level</org_study_id>
    <nct_id>NCT01306565</nct_id>
  </id_info>
  <brief_title>High Dose and Low Dose of Atorvastatin in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)</brief_title>
  <official_title>Comparison Between Effect of High Dose and Low Dose of Atorvastatin in Reduction Level of CRP in Patients With Unstable Angina and NSTEMI (Non ST Elevation MI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hormozgan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hormozgan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare the effect of high dose and low dose of Atorvastatin in
      reduction level of C-reactive protein (CRP) in patients with unstable angina and NSTEMI (Non
      ST Elevation MI) attending Shahid Mohammadi hospital in Bandar Abbas.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study compare the effect of 80mg atorvastatin followed by two 20mg daily atorvastatin
      with three 80mg daily atorvastatin in reduction of CRP in patients with unstable angina and
      NSTEMI (Non ST Elevation MI) attending Shahid Mohammadi hospital in Bandar Abbas in 2009.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">January 2011</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>CRP reduction</measure>
    <time_frame>72 hours</time_frame>
    <description>CRP reduction will be compared between two study groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Drug side effects</measure>
    <time_frame>72 hours</time_frame>
    <description>Headache, Myopathy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>High dose atorvastatin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Three 80mg daily doses of atorvastatin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose Atorvastatin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>80mg atorvastatin followed by two 20mg daily atorvastatin</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Low dose Atorvastatin</intervention_name>
    <description>80mg atorvastatin followed by two 20mg daily atorvastatin</description>
    <arm_group_label>High dose atorvastatin</arm_group_label>
    <other_name>Lipitor</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>High dose atorvastatin</intervention_name>
    <description>80mg daily atorvastatin for 72 hours</description>
    <arm_group_label>Low dose Atorvastatin</arm_group_label>
    <other_name>Lipitor</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with unstable angina with chest discomfort at rest with normal EKG or St
             depression (at least 0.1mv) in two consecutive leads or new and deep T inversion (at
             least 0.2mv)

        Exclusion Criteria:

          -  Myocardial Infarction with ST elevation

          -  Diabetes Mellitus

          -  Previous statin use

          -  Current infectious disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vahid Vahdatkhah</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hormozgan University of Medical Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hormozgan University of Medical Sciences</name>
      <address>
        <city>Bandar Abbas</city>
        <state>Hormozgan</state>
        <zip>097145-3388</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>November 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2011</study_first_submitted>
  <study_first_submitted_qc>March 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2011</study_first_posted>
  <last_update_submitted>March 1, 2011</last_update_submitted>
  <last_update_submitted_qc>March 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Vahid Vahdatkhah</name_title>
    <organization>Hormozgan University of Medical Sciences</organization>
  </responsible_party>
  <keyword>Unstable angina</keyword>
  <keyword>NSTMI</keyword>
  <keyword>Statin</keyword>
  <keyword>Atorvastatin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Angina, Unstable</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atorvastatin Calcium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

